RSS

TECO Treaty Energy Corporation

Last Post: 03/24/22
Followers: 93
Posts Today: 0
Views Today: 6281

TECO Stock Quote & Tools

$— ▲ +0.0000 (+0.00%)
Last—
$ Chg0.0000
Open—
High—
Beta-167.3862
Year High0.009
Market Cap—
P/B Ratio—
EPS—
Avg Vol (30d)1.55M
Volume—
% Chg+0.00%
Prev Close—
Low—
VWAP—
Year Low0.000
Total Shares—
Shares Out—
Float2.13B
Exchange
Energy Fossil Fuels

TECO Stock Message Board Discussion

  1. BULL2222
  2. BULL2222
  3. BULL2222
  4. BULL2222
  5. BigSur25
  6. BigSur25

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 655

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 0

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise of the Aluminum Alloy Wheel Market

Updated Category News Views 91

Overview of the Aluminum Alloy Wheel Market The Aluminum Alloy Wheel market has experienced notable growth and shows a bright future ahead. With ongoing innovations from manufacturers and shifting consumer preferences, the market is projected to reach approximately USD 33.2 billion by 2033. This growth translates to an estimated compound annual growth rate (CAGR) of 7.2%...

Continue Reading
Prominent Speakers Set to Illuminate Fortune Global Forum

Updated Category News Views 191

Global Icons to Speak at Fortune Global Forum 2024 Excitement is building around the upcoming Fortune Global Forum, where some of the most influential leaders in business and policy will converge. This event, set for November 11-12, promises rich dialogues on pressing global issues. Among the key figures attending are Tom Brady, the renowned seven-time world champion, and...

Continue Reading
IGT Unveils Diverse Wheel of Fortune Products at G2E 2024

Updated Category News Views 187

IGT Launches Exciting New Offerings for Wheel of Fortune International Game Technology PLC, better known as IGT, is famous for creating vibrant and engaging gaming experiences. At the upcoming Global Gaming Expo (G2E), IGT will proudly showcase a range of new products dedicated to the beloved Wheel of Fortune brand. Attendees can look forward to an exciting lineup that...

Continue Reading
Market Dynamics and Short Selling Insights About Disney

Updated Category News Views 132

Understanding Short Selling for Walt Disney Walt Disney's short percent of float has experienced a notable increase, now standing at 8.04% from the latest report. Presently, there are 21.70 million shares sold short, which accounts for 1.21% of all available regular shares. With the current trading volume, it is estimated that it would take around 3.12 days on average for...

Continue Reading
Heritage Commerce Corp Announces Quarterly Dividend of $0.13

Updated Category News Views 155

Heritage Commerce Corp Declares Dividend to Shareholders Heritage Commerce Corp (NASDAQ: HTBK), a respected bank holding company in the financial sector, recently shared exciting news with its stakeholders. The Board of Directors has approved a cash dividend of $0.13 per share for all common stock holders. This positive announcement reflects the company's commitment to...

Continue Reading